Anesthetic management for robotic hysterectomy in obese women.

Abstract

PURPOSE OF REVIEW:

Obesity is a major health epidemic, with the prevalence reaching ∼40% in the United States in recent years. It is associated with increased risk of hypertension, diabetes, heart disease, stroke, obstructive sleep apnea (OSA), and gynecologic conditions requiring surgery. Those comorbidities, in addition to the physiologic changes associated with obesity, lead to increased risk of perioperative complications. The purpose of this review is to highlight the anesthetic considerations for robotic assisted hysterectomy in obese patients.

RECENT FINDINGS:

In the general gynecologic population, minimally invasive surgery is associated with less postoperative fever, pain, hospital length of stay, total cost of care and an earlier return to normal function. This also applies to robotic surgery in obese patients, which is on the rise. The physiologic changes of obesity bring different anesthetic challenges, including airway management and intraoperative ventilation. Vascular access and intraoperative blood pressure monitoring can also be challenging and require modifications. Optimizing analgesia with a focus on opioid-sparing strategies is crucial due to the increased prevalence of OSA in this patient population.

SUMMARY:

Anesthesia for obese patients undergoing robotic hysterectomy is challenging and must take into consideration the anatomic and physiologic changes associated with obesity.

• Authors: Mary Yurashevich, Ashraf S Habib
• Journal: Current opinion in anaesthesiology (Curr Opin Anaesthesiol) Vol. 34 Issue 3 Pg. 238-245 (Jun 01 2021) ISSN: 1473-6500 [Electronic] United States
• PMID: 33935171 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Chemical References

• Anesthetics

Topics

• Anesthetics
• Female
• Humans
• Hysterectomy (adverse effects)
• Obesity (complications, epidemiology)
• Postoperative Complications
• Robotic Surgical Procedures (adverse effects)